Irbesartan vs Nivolumab
Irbesartan vs Nivolumab: Overview
This comparison examines the pharmacological differences between Irbesartan and Nivolumab.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Irbesartan — 11-15 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Irbesartan — C25H28N6O.
Molecular Weight: Irbesartan — 428.5320 g/mol.
Type: Irbesartan — Small molecule; Nivolumab — Antibody.